Research illuminates a therapeutic strategy to induce cancer cell death

by Rachel Sauer,CU Anschutz Medical CampusCredit: CC0 Public DomainCancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors a

Oncology January 22,2024

Research illuminates a therapeutic strategy to induce cancer cell death

by Rachel Sauer,CU Anschutz Medical CampusCredit: CC0 Public DomainCancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors a

Oncology January 22,2024

Study shows how morphine may contribute to bone loss and cancer-induced bone pain

by Stacy Pigott,University of ArizonaOn the left, cells isolated from breast cancer cells were treated with RANKL, a growth factor that stimulates bone resorption, to produce osteoclasts (pink).

Oncology January 22,2024

Study shows how morphine may contribute to bone loss and cancer-induced bone pain

by Stacy Pigott,University of ArizonaOn the left, cells isolated from breast cancer cells were treated with RANKL, a growth factor that stimulates bone resorption, to produce osteoclasts (pink).

Oncology January 22,2024

Research shows that lymph node sampling during kidney tumor surgery is safe

by Rachel Sauer,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainA longstanding approach to surgeries for children with kidney tumors has been an abundance of caution.While a growing b

Oncology January 22,2024

Research shows that lymph node sampling during kidney tumor surgery is safe

by Rachel Sauer,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainA longstanding approach to surgeries for children with kidney tumors has been an abundance of caution.While a growing b

Oncology January 22,2024

Study suggests chromosomal errors may hinder some aggressive tumors

by Julie Vera,Mayo ClinicGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.100937Chromosomal errors are a hallmark of cancer cells. Defects in the geno

Oncology January 22,2024

Study suggests chromosomal errors may hinder some aggressive tumors

by Julie Vera,Mayo ClinicGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.100937Chromosomal errors are a hallmark of cancer cells. Defects in the geno

Oncology January 22,2024

Study links reconstructive surgery after breast cancer to changes in upper limb movement

byUniversity of SaskatchewanCredit: Unsplash/CC0 Public DomainA recently published study authored by a pair of University of Saskatchewan (USask) researchers shows that reconstructive surgery af

Oncology January 22,2024

Study links reconstructive surgery after breast cancer to changes in upper limb movement

byUniversity of SaskatchewanCredit: Unsplash/CC0 Public DomainA recently published study authored by a pair of University of Saskatchewan (USask) researchers shows that reconstructive surgery af

Oncology January 22,2024

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Oncology January 22,2024

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Oncology January 22,2024

To rev-up CAR T-cell therapy, inhibit the SUSD2 membrane protein, study suggests

byOhio State University Medical CenterCredit: Pixabay/CC0 Public DomainInhibiting a particular protein in cancer-killing immune cells might improve the long-term effectiveness of CAR T-cell and

Oncology January 22,2024

To rev-up CAR T-cell therapy, inhibit the SUSD2 membrane protein, study suggests

byOhio State University Medical CenterCredit: Pixabay/CC0 Public DomainInhibiting a particular protein in cancer-killing immune cells might improve the long-term effectiveness of CAR T-cell and

Oncology January 22,2024

Study links poverty to increased acute lymphoblastic leukemia relapse

by Brianna Hoge,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainA new study from the University of Alabama at Birmingham's Marnix E. Heersink School of Medicine suggests

Oncology January 22,2024

Study links poverty to increased acute lymphoblastic leukemia relapse

by Brianna Hoge,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainA new study from the University of Alabama at Birmingham's Marnix E. Heersink School of Medicine suggests

Oncology January 22,2024

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Oncology January 22,2024

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Oncology January 22,2024

Blood cancer manipulates immune cells in order to survive, study shows

byWellcome Trust Sanger InstituteCredit: Pixabay/CC0 Public DomainThe most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumor ce

Oncology January 22,2024

Blood cancer manipulates immune cells in order to survive, study shows

byWellcome Trust Sanger InstituteCredit: Pixabay/CC0 Public DomainThe most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumor ce

Oncology January 22,2024